Search Within

Anthony Joseph Proli II

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (9)
  2. Department of Medicine (9)
  3. Epidemiology and Biostatistics (9)
  4. Hematologic Malignancies, Division of (9)
  5. Bone Marrow Transplant (8)
  6. Center for Hematologic Malignancies (8)

More Groups

People
  1. Sean Devlin (9)
  2. Sergio Giralt (8)
  3. Andrew Lin (7)
  4. Ann Jakubowski (5)
  5. Esperanza Papadopoulos (5)
  6. Miguel-Angel Perales (5)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (2)
  4. 2019 (1)
  5. 2017 (1)
  6. 2016 (2)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (3)
  2. Blood (2)
  3. Bone Marrow Transplantation (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Leukemia and Lymphoma (1)
  6. Transplantation and Cellular Therapy (1)
Publishers
  1. Elsevier Inc. (5)
  2. American Society of Hematology (2)
  3. Nature Publishing Group (1)
  4. Taylor & Francis Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation
    Journal Article

    Lin, A.; Brown, S.; Maloy, M.; Ruiz, J. D.; Devlin, S.; DeRespiris, L.; Proli, A.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Letermovir for prevention of cytomegalovirus reactivation in haploidentical and mismatched adult donor allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis
    Journal Article

    Lin, A.; Flynn, J.; DeRespiris, L.; Figgins, B.; Griffin, M.; Lau, C.; Proli, A.; Devlin, S. M.; Cho, C.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
    Research Letter

    Maples, K. T.; Maloy, M.; Devlin, S.; Lin, A.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Papanicolaou, G. A.; Seo, S. K.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful personalization of propylene glycol free melphalan (PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) using pharmacokinetic (PK)-directed dosing
    Meeting Abstract

    Shah, G. L.; Lin, A.; Kamrowski, A.; Carino, C. A.; Schofield, R.; Devlin, S. M.; Bhatt, V.; Proli, A. J.; Chung, D. J.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with relapsed multiple myeloma undergoing CD34-selected allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Lin, A.; Drill, E.; Proli, A. J.; Beyer, K.; Bhatt, V.; Devlin, S. M.; Koehne, G.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Beyer, K.; Proli, A.; Zheng, J.; Devlin, S.; Bhatt, V.; Lin, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Perales, M.; Giralt, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with advanced myelodysplastic syndrome undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Proli, A. J.; Tamari, R.; Zheng, J.; Jakubowski, A. A.; Papadopoulos, E.; Ponce, D. M.; Devlin, S. M.; Sauter, C. S.; Perales, M. A.; Young, J. W.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Impact of busulphan exposure on transplant outcomes for patients with advanced myelodysplastic syndromes undergoing CD34 selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Tamari, R.; Proli, A.; Zheng, J. T.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Devlin, S.; Sauter, C. S.; Young, J. W.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save